FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nanette Wenger

Research Profile

Concepts & Ideas

Disorders

Chemicals & Drugs

Activities & Behaviors

Life Style

Occupations

Evidence-Based Medicine

Co-author Network

Publications

TOP 3
Nanette K Wenger
Hormone therapy not recommended for chronic disease prevention in menopausal women.
Lori B Daniels; Deborah Grady; Bruce H Mitlak; Lori Mosca; Nanette K Wenger; Messan G Amewou-Atisso; Elizabeth Barrett-Connor; Peter Collins
Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial.
William E Boden; Barry A Franklin; Nanette K Wenger
Physical activity and structured exercise for patients with stable ischemic heart disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nanette Wenger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nanette K Wenger
Hormone therapy not recommended for chronic disease prevention in menopausal women.
Evidence-based medicine 2013;18(3):109-10.
2013: Lori B Daniels; Deborah Grady; Bruce H Mitlak; Lori Mosca; Nanette K Wenger; Messan G Amewou-Atisso; Elizabeth Barrett-Connor; Peter Collins
Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial.
Circulation. Cardiovascular quality and outcomes 2013;6(2):164-70.
2013: William E Boden; Barry A Franklin; Nanette K Wenger
Physical activity and structured exercise for patients with stable ischemic heart disease.
JAMA : the journal of the American Medical Association 2013;309(2):143-4.
2013: Larry F Hamm; Carl J Lavie; Todd D Miller; Ross Arena; Daniel E Forman; Nanette K Wenger; Randal J Thomas
Cardiac rehabilitation and cardiovascular disability: role in assessment and improving functional capacity: a position statement from the American Association of Cardiovascular and Pulmonary Rehabilitation.
Journal of cardiopulmonary rehabilitation and prevention 2013;33(1):1-11.
2013: Jennifer J Stuart; Nanette K Wenger; Chrisandra Shufelt; Meir Steiner; C Noel Bairey-Merz; Sarah L Berga; Virginia M Miller; Pamela Ouyang; Janet W Rich-Edwards
Maternal recall of hypertensive disorders in pregnancy: a systematic review.
Journal of women's health (2002) 2013;22(1):37-47.
2012: Nanette K Wenger
Gender disparity in cardiovascular disease: bias or biology?
Expert review of cardiovascular therapy 2012;10(11):1401-11.
2012: Nanette K Wenger
What's new in antiplatelet and anticoagulant therapy recommendations for unstable angina/non-ST-elevation myocardial infarction: 2012 focused update from the American College of Cardiology Foundation/American Heart Association task force on practice guidelines.
Clinical cardiology 2012;35(11):669-72.
2012: Vera Bittner; David A DeMicco; Michael Messig; David D Waters; Nanette K Wenger; John C LaRosa
Vitamin D levels do not predict cardiovascular events in statin-treated patients with stable coronary disease.
American heart journal 2012;164(3):387-93.
2012: Philip Green; Mathew S Maurer; JoAnne M Foody; Daniel E Forman; Nanette K Wenger
Representation of older adults in the late-breaking clinical trials American Heart Association 2011 Scientific Sessions.
Journal of the American College of Cardiology 2012;60(9):869-71.
2012: Hani Jneid; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; R Scott Wright; Cynthia D Adams; Jeffrey L Anderson; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; James Patrick Zidar
2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Journal of the American College of Cardiology 2012;60(7):645-81.
2012: Cynthia D Adams; Jeffrey L Anderson; Jeffrey L Anderson; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; Hani Jneid; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; R Scott Wright; James Patrick Zidar
2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
Circulation 2012;126(7):875-910.
2012: Nanette K Wenger
Women and coronary heart disease: a century after Herrick: understudied, underdiagnosed, and undertreated.
Circulation 2012;126(5):604-11.
2012: Samia Mora; Nanette K Wenger; Benoit J Arsenault; S Matthijs Boekholdt; Andrei Breazna; Prakash Deedwania; David A Demicco; John J P Kastelein; David D Waters
Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) study.
Circulation 2012;125(16):1979-87.
2012: Andrew J Canto; Paul D Frederick; Robert J Goldberg; Catarina I Kiefe; Eric D Peterson; William J Rogers; George Sopko; Viola Vaccarino; Nanette K Wenger; Zhi-Jie Zheng; John G Canto
Differences in symptom presentation and hospital mortality according to type of acute myocardial infarction.
American heart journal 2012;163(4):572-9.
2012: Divya Gupta; Nanette K Wenger
Guidelines for the prevention of cardiovascular disease in women: international challenges and opportunities.
Expert review of cardiovascular therapy 2012;10(3):379-85.
2012: Nanette K Wenger
Cardiovascular disease: the female heart is vulnerable: a call to action from the 10Q report.
Clinical cardiology 2012;35(3):134-5.
2012: Niels Engberding; Nanette K Wenger
Management of hypertension in women.
Hypertension research : official journal of the Japanese Society of Hypertension 2012;35(3):251-60.
2012: John G Canto; Paul D Frederick; Robert J Goldberg; Catarina I Kiefe; Eric D Peterson; William J Rogers; George Sopko; Viola Vaccarino; Nanette K Wenger; Zhi-Jie Zheng
Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality.
JAMA : the journal of the American Medical Association 2012;307(8):813-22.
2011: Nanette K Wenger
Coronary heart disease in men and women: does 1 size fit all? No!
Clinical cardiology 2011;34(11):663-7.
2011: Erin M Galbraith; Puja K Mehta; Viola Vaccarino; Emir Veledar; Nanette K Wenger
Women and heart disease: knowledge, worry, and motivation.
Journal of women's health (2002) 2011;20(10):1529-34.
2011: Leslee J Shaw; Emir Veledar; Nanette K Wenger; James A Arrighi; William E Boden; Raymond J Gibbons; Martha Gulati; Rory Hachamovitch; Gary V Heller; Robert Charles Hendel; C Noel Bairey Merz; Jennifer H Mieres
Comparative effectiveness of exercise electrocardiography with or without myocardial perfusion single photon emission computed tomography in women with suspected coronary artery disease: results from the What Is the Optimal Method for Ischemia Evaluation in Women (WOMEN) trial.
Circulation 2011;124(11):1239-49.
2011: Nanette K Wenger
What do the 2011 American Heart Association guidelines tell us about prevention of cardiovascular disease in women?
Clinical cardiology 2011;34(9):520-3.
2011: Charles F Jackson; Nanette K Wenger
Cardiovascular disease in the elderly.
Revista española de cardiología 2011;64(8):697-712.
2011: Nanette K Wenger
Science and the practice of cardiovascular medicine in the geriatric population.
Journal of geriatric cardiology : JGC 2011;8(2):67-71.
2011: R Scott Wright; Jeffrey L Anderson; Cynthia D Adams; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; Hani Jneid; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; James Patrick Zidar; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; James Patrick Zidar
2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons.
Journal of the American College of Cardiology 2011;57(19):e215-367.
2011: R Scott Wright; Jeffrey L Anderson; Cynthia D Adams; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; Hani Jneid; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; James Patrick Zidar; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette K Wenger; R Scott Wright
2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
Journal of the American College of Cardiology 2011;57(19):1920-59.
2011: R Scott Wright; Jeffrey L Anderson; Cynthia D Adams; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; Hani Jneid; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; James Patrick Zidar; Alice K Jacobs
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Circulation 2011;123(18):2022-60.
2011: Daniel E Forman; Michael W Rich; Karen P Alexander; Susan J Zieman; Mathew S Maurer; Samer S Najjar; Joseph C Cleveland; Harlan M Krumholz; Nanette K Wenger
Cardiac care for older adults. Time for a new paradigm.
Journal of the American College of Cardiology 2011;57(18):1801-10.
2011: Ori Ben-Yehuda; Christian Constance; Mary E Hanson; Charlotte Jones-Burton; Jian-Xin Lin; Arvind K Shah; Nanette K Wenger; Franklin Zieve; Andrew M Tershakovec
The comparative efficacy of ezetimibe added to atorvastatin 10 mg versus uptitration to atorvastatin 40 mg in subgroups of patients aged 65 to 74 years or greater than or equal to 75 years.
Journal of geriatric cardiology : JGC 2011;8(1):1-11.
2011: Nanette K Wenger
Women's heart health: a worldwide challenge.
Cardiology in review 2011;19(2):58-9.
2011: Judith E Mitchell; Keith C Ferdinand; Karol E Watson; Nanette K Wenger; Laurence O Watkins; John M Flack; James R Gavin; James _ Reed; Elijah Saunders; Jackson T Wright
Treatment of heart failure in African Americans--a call to action.
Journal of the National Medical Association 2011;103(2):86-98.
2011: Benoit J Arsenault; Philip Barter; David A DeMicco; Weihang Bao; Gregory M Preston; John C LaRosa; Scott M Grundy; Prakash Deedwania; Heiner Greten; Nanette K Wenger; James Shepherd; David D Waters; John J P Kastelein
Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers.
Journal of the American College of Cardiology 2011;57(1):63-9.
2011: Virginia M Miller; Pamela Ouyang; Sarah L Berga; Jay R Kaplan; Monica Mallampalli; C Noel Bairey Merz; Nicholas J Schork; Leslee J Shaw; Meir Steiner; Doris A Taylor; R Clinton Webb; Nanette K Wenger; Jane F Reckelhoff
Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists.
Biology of sex differences 2011;2():14.
2010: Philip Greenland; Joseph S Alpert; George A Beller; Emelia J Benjamin; Matthew J Budoff; Zahi A Fayad; Elyse Foster; Mark A Hlatky; John McB Hodgson; Frederick G Kushner; Michael S Lauer; Leslee J Shaw; Sidney C Smith; Allen J Taylor; William S Weintraub; Nanette K Wenger; Alice K Jacobs
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Circulation 2010;122(25):e584-636.
2010: Philip Greenland; Joseph S Alpert; George A Beller; Emelia J Benjamin; Matthew J Budoff; Zahi A Fayad; Elyse Foster; Mark A Hlatky; John McB Hodgson; Frederick G Kushner; Michael S Lauer; Leslee J Shaw; Sidney C Smith; Allen J Taylor; William S Weintraub; Nanette K Wenger; Alice K Jacobs
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Circulation 2010;122(25):2748-64.
2010: Nanette K Wenger; Jennifer M Mischke; Rolf Schroeder; Klaus Schroeder; Peter Collins; Deborah Grady; Marcel Kornitzer; Lori Mosca; Elizabeth Barrett-Connor
Electrocardiograms of menopausal women with coronary heart disease or at increased risk for its occurrence.
The American journal of cardiology 2010;106(11):1580-7.
2010: Nanette K Wenger
Angina in women.
Current cardiology reports 2010;12(4):307-14.
2010: Jodi R Godfrey; Nanette K Wenger
Toward optimal health: advances in the cardiovascular care of women. [An interview with Jodi R. Godfrey and Wenger K. Nanette].
Journal of women's health (2002) 2010;19(4):659-64.
2010: Nanette K Wenger
The female heart is vulnerable to cardiovascular disease: emerging prevention evidence for women must inform emerging prevention strategies for women.
Circulation. Cardiovascular quality and outcomes 2010;3(2):118-9.
2010: Franklin Zieve; Nanette K Wenger; Ori Ben-Yehuda; Christian Constance; Steven Bird; Raymond Lee; Mary E Hanson; Charlotte Jones-Burton; Andrew M Tershakovec
Safety and efficacy of ezetimibe added to atorvastatin versus up titration of atorvastatin to 40 mg in Patients > or = 65 years of age (from the ZETia in the ELDerly [ZETELD] study).
The American journal of cardiology 2010;105(5):656-63.
2010: John C LaRosa; Prakash C Deedwania; James Shepherd; Nanette K Wenger; Heiner Greten; David A DeMicco; Andrei Breazna
Comparison of 80 versus 10 mg of atorvastatin on occurrence of cardiovascular events after the first event (from the Treating to New Targets [TNT] trial).
The American journal of cardiology 2010;105(3):283-7.
2010: David S Vadnais; Nanette K Wenger
Emerging clinical role of ranolazine in the management of angina.
Therapeutics and clinical risk management 2010;6():517-30.
2009: Jordan W Smoller; Matthew Allison; Barbara B Cochrane; J David Curb; Roy H Perlis; Jennifer G Robinson; Milagros C Rosal; Nanette K Wenger; Sylvia Wassertheil-Smoller
Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study.
Archives of internal medicine 2009;169(22):2128-39.
2009: Nanette K Wenger
Menopausal hormone therapy for cardiovascular protection--unfulfilled expectations.
Journal of cardiovascular translational research 2009;2(3):286-8.
2009: Susmita Parashar; Ronit Katz; Nicholas L Smith; Alice M Arnold; Viola Vaccarino; Nanette K Wenger; John S Gottdiener
Race, gender, and mortality in adults > or =65 years of age with incident heart failure (from the Cardiovascular Health Study).
The American journal of cardiology 2009;103(8):1120-7.
2009: Peter Collins; Lori Mosca; Mary Jane Geiger; Deborah Grady; Marcel Kornitzer; Messan G Amewou-Atisso; Mark B Effron; Sherie A Dowsett; Elizabeth Barrett-Connor; Nanette K Wenger
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors.
Circulation 2009;119(7):922-30.
2009: Maan Jokhadar; Nanette K Wenger
Review of the treatment of acute coronary syndrome in elderly patients.
Clinical interventions in aging 2009;4():435-44.
2008: Jennifer S McCall-Hosenfeld; Sarah A Jaramillo; Claudine Legault; Karen M Freund; Barbara B Cochrane; JoAnn E Manson; Nanette K Wenger; Charles B Eaton; Beatriz L Rodriguez; S Gene McNeeley; Denise Bonds
Correlates of sexual satisfaction among sexually active postmenopausal women in the Women's Health Initiative-Observational Study.
Journal of general internal medicine 2008;23(12):2000-9.
2008: Niels Engberding; Nanette K Wenger
Cardiovascular disease prevention tailored for women.
Expert review of cardiovascular therapy 2008;6(8):1123-34.
2008: James Shepherd; John P Kastelein; Vera A Bittner; Rafael Carmena; Prakash C Deedwania; Andrei Breazna; Stephen Dobson; Daniel J Wilson; Andrea L Zuckerman; Nanette K Wenger
Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease.
Mayo Clinic proceedings. Mayo Clinic 2008;83(8):870-9.
2008: Lesley Tinker; Denise E Bonds; Karen L Margolis; JoAnn E Manson; Barbara V Howard; Joseph Larson; Michael G Perri; Shirley A A Beresford; Jennifer G Robinson; Beatriz L Rodriguez; Monika Maria Safford; Nanette K Wenger; Victor J. Stevens; Linda M. Parker
Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial.
Archives of internal medicine 2008;168(14):1500-11.
2008: Deborah Grady; Jane A Cauley; Mary Jane Geiger; Marcel Kornitzer; Lori Mosca; Peter Collins; Nanette K Wenger; Jingli Song; John Mershon; Elizabeth Barrett-Connor
Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk.
Journal of the National Cancer Institute 2008;100(12):854-61.
2008: Sanjiv J Shah; David D Waters; Philip Barter; John J P Kastelein; James Shepherd; Nanette K Wenger; David A DeMicco; Andrei Breazna; John C LaRosa
Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery.
Journal of the American College of Cardiology 2008;51(20):1938-43.
2008: Nanette K Wenger
Current status of cardiac rehabilitation.
Journal of the American College of Cardiology 2008;51(17):1619-31.
2008: James Shepherd; John J P Kastelein; Vera Bittner; Prakash Deedwania; Andrei Breazna; Stephen Dobson; Daniel J Wilson; Andrea Zuckerman; Nanette K Wenger
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.
Journal of the American College of Cardiology 2008;51(15):1448-54.
2008: Jennifer S McCall-Hosenfeld; Karen M Freund; Claudine Legault; Sarah A Jaramillo; Barbara B Cochrane; JoAnn E Manson; Nanette K Wenger; Charles B Eaton; S Gene McNeeley; Beatriz L Rodriguez; Denise Bonds
Sexual satisfaction and cardiovascular disease: the Women's Health Initiative.
The American journal of medicine 2008;121(4):295-301.
2008: Nanette K Wenger; Sandra Lewis; Francine K Welty; David M Herrington; V Bittner
Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study.
Heart (British Cardiac Society) 2008;94(4):434-9.
2008: Nanette K Wenger
Women in leadership positions in the medical academic enterprise: what are the next steps?
Archives of internal medicine 2008;168(5):449-50.
2008: Peter R Kowey; Nanette K Wenger; Michael A Weber; Carl J Lavie
The geriatric paradox.
The American journal of geriatric cardiology 2008;17(2):69-70.
2008: Nanette K Wenger
Preventing cardiovascular disease in women: an update.
Clinical cardiology 2008;31(3):109-13.
2008: Nanette K Wenger
Drugs for cardiovascular disease prevention in women: implications of the AHA Guidelines--2007 Update.
Drugs 2008;68(3):339-58.
2008: Gene P Snyder; Elizabeth B Ferretti; Nanette K Wenger; John E Strobeck; Marc A Silver; James R Sowers; Marguerite M Engler; Ezra A Amsterdam; Sylvan Lee Weinberg; Lawrence Charles Parish; Marvin Moser
Accountability and transparency in medical publishing: position and policies of le jacq on authorship, acknowledgments, conflicts of interest, and secondary and redundant publication.
The American heart hospital journal 2008;6(1):5-8.
2008: Michael A Weber; Nanette K Wenger
Progress in treating hypertension.
The American journal of geriatric cardiology 2008;17(1):5-6.
2008: Nanette K Wenger
Women, their age, and their cholesterol values.
Cardiology in review 2008;16(1):21-2.
2007: Nanette K Wenger
Do diet, folic acid, and vitamins matter? What did we learn from the Women's Health Initiative, the Women's Health Study, the Women's Antioxidant and Folic Acid Cardiovascular Study, and other clinical trials?
Cardiology in review 2007;15(6):288-90.
2007: Nanette K Wenger
Exploring sex/gender differences in women's cardiovascular health.
Cardiology in review 2007;15(6):273-4.
2007: Nanette K Wenger; Michael A Weber
Newer diagnostic strategies, application of evidence-based therapies: improving cardiovascular outcomes in an expanding elderly population.
The American journal of geriatric cardiology 2007;16(6):337-8.
2007: James Shepherd; John J P Kastelein; Vera Bittner; Prakash Deedwania; Andrei Breazna; Stephen Dobson; Daniel J Wilson; Andrea Zuckerman; Nanette K Wenger
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study.
Clinical journal of the American Society of Nephrology : CJASN 2007;2(6):1131-9.
2007: Michael A Weber; Nanette K Wenger
Drug choice affects treatment compliance and blood pressure outcomes in elderly hypertensive patients.
The American journal of geriatric cardiology 2007;16(5):277-8.
2007: Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette K Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Jonathan L Halperin; Sharon Ann Hunt; Harlan Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.
Journal of the American College of Cardiology 2007;50(7):e1-e157.
2007: Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette K Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Jonathan L Halperin; Sharon Ann Hunt; Harlan Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.
Circulation 2007;116(7):e148-304.
2007: Nanette K Wenger
Heightened cardiovascular risk in diabetic women: can the tide be turned?
Annals of internal medicine 2007;147(3):208-10.
2007: Nanette K Wenger; Sandra Lewis; David M Herrington; Vera Bittner; Francine K Welty
Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease.
Annals of internal medicine 2007;147(1):1-9.
2007: Stephen Scheidt; Nanette K Wenger; Michael A Weber
Patient selection, statistical presumption, and uncertainty of outcomes.
The American journal of geriatric cardiology 2007;16(4):213-5.
2007: Nanette K Wenger
The Reynolds Risk Score: improved accuracy for cardiovascular risk prediction in women?
Nature clinical practice. Cardiovascular medicine 2007;4(7):366-7.
2007: Nanette K Wenger; Stephen Scheidt; Michael Weber
Cardiovascular risk factors, cardiovascular disease, cardiovascular drug therapies, and dementia/cognitive dysfunction: how do the pieces of the puzzle fit together?
The American journal of geriatric cardiology 2007;16(3):133-5.
2007: Paul D Thompson; Barry A Franklin; Gary J Balady; Steven N Blair; Domenico Corrado; N A Mark Estes; Janet E Fulton; Neil F Gordon; William L Haskell; Mark S Link; Barry J Maron; Murray A Mittleman; Antonio Pelliccia; Nanette K Wenger; Stefan N Willich; Fernando Costa
Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology.
Circulation 2007;115(17):2358-68.
2007: Nanette K Wenger
The greying of cardiology: implications for management.
Heart (British Cardiac Society) 2007;93(4):411-2.
2007: Michael Weber; Nanette K Wenger; Stephen Scheidt
Observational studies can help fill important gaps in understanding and treating cardiovascular disease in the elderly.
The American journal of geriatric cardiology 2007;16(2):65-6.
2007: Judith Hsia; Karen L Margolis; Charles B Eaton; Nanette K Wenger; Matthew Allison; LieLing Wu; Andrea Z LaCroix; Henry R Black
Prehypertension and cardiovascular disease risk in the Women's Health Initiative.
Circulation 2007;115(7):855-60.
2007: Kiran K Khush; David D Waters; Vera Bittner; Prakash C Deedwania; John J P Kastelein; Sandra Lewis; Nanette K Wenger
Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study.
Circulation 2007;115(5):576-83.
2007: Stephen Scheidt; Nanette K Wenger; Michael A Weber
Denial of standard treatment to the elderly: why?
The American journal of geriatric cardiology 2007;16(1):5-7.
2007: Nanette K Wenger; Bernard R Chaitman; George W Vetrovec
Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials.
The American journal of cardiology 2007;99(1):11-8.
2006: Nanette K Wenger
Enrollment and maintenance of elderly patients in cardiovascular clinical trials.
The American journal of geriatric cardiology 2006;15(6):352-6.
2006: Michael A Weber; Nanette K Wenger; Stephen Scheidt
Who should be treated with implantable cardioverter-defibrillators?
The American journal of geriatric cardiology 2006;15(6):336-7.
2006: Nanette K Wenger
Lipid abnormalities in women: data for risk, data for management.
Cardiology in review 2006;14(6):276-80.
2006: Susmita Parashar; John S Rumsfeld; John A Spertus; Kimberly J Reid; Nanette K Wenger; Harlan Krumholz; Alpesh Amin; William S Weintraub; Judith H Lichtman; Nazeera Dawood; Viola Vaccarino
Time course of depression and outcome of myocardial infarction.
Archives of internal medicine 2006;166(18):2035-43.
2006: Nanette K Wenger
[Menopausal hormone therapy and cardiovascular disease].
Revista española de cardiología 2006;59(10):1058-69.
2006: Nanette K Wenger; Michael A Weber; Stephen Scheidt
Valvular heart disease at elderly age: new vistas.
The American journal of geriatric cardiology 2006;15(5):273-4.
2006: Mardi Gomberg-Maitland; Nanette K Wenger; Jan Feyzi; Maria Lengyel; Annabelle S Volgman; Palle Petersen; Lars Frison; Jonathan L Halperin
Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials.
European heart journal 2006;27(16):1947-53.
2006: Elizabeth Barrett-Connor; Lori Mosca; Peter Collins; Mary Jane Geiger; Deborah Grady; Marcel Kornitzer; Michelle A McNabb; Nanette K Wenger
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.
The New England journal of medicine 2006;355(2):125-37.
2006: Edgar Argulian; Amar D Patel; Jerome L Abramson; Aniket Kulkarni; Kimberly P Champney; Spencer Palmer; William S Weintraub; Nanette K Wenger; Viola Vaccarino
Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions.
The American journal of cardiology 2006;98(1):48-53.
2006: Nanette K Wenger; Michael A Weber; Stephen Scheidt
Coronary risk attributes, coronary risk reduction, and clinical outcomes.
The American journal of geriatric cardiology 2006;15(3):140-1.
2006: Susmita Mallik; John A Spertus; Kimberly J Reid; Harlan Krumholz; John S Rumsfeld; William S Weintraub; Purva Agarwal; Mugdha Santra; Savita Bidyasar; Judith H Lichtman; Nanette K Wenger; Viola Vaccarino
Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women.
Archives of internal medicine 2006;166(8):876-83.
2006: Nanette K Wenger
Coronary heart disease in women: highlights of the past 2 years--stepping stones, milestones and obstructing boulders.
Nature clinical practice. Cardiovascular medicine 2006;3(4):194-202.
2006: W Dallas Hall; Laurence O Watkins; Jackson T Wright; Nanette K Wenger; Shiriki K Kumanyika; James R Gavin; Keith C Ferdinand; Karol Watson; Luther Clark; John M Flack; James _ Reed; Ella W Horton; Elijah Saunders
The metabolic syndrome: recognition and management.
Disease management : DM 2006;9(1):16-33.
2006: Khan Pohlel; Parker Grow; Tarek Helmy; Nanette K Wenger
Treating dyslipidemia in the elderly.
Current opinion in lipidology 2006;17(1):54-7.
2005: Nanette K Wenger; Mary Jane Geiger
Baseline characteristics of menopausal women with coronary heart disease in cardiovascular outcomes clinical trials of menopausal hormone therapy or raloxifene.
Contemporary clinical trials 2005;26(6):612-5.
2005: Marjorie L King; Mark A Williams; Gerald F Fletcher; Neil F Gordon; Meg Gulanick; Carl N King; Arthur S Leon; Benjamin D Levine; Fernando Costa; Nanette K Wenger
Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs: a scientific statement from the American Heart Association/American Association for Cardiovascular and Pulmonary Rehabilitation.
Circulation 2005;112(21):3354-60.
2005: Marjorie L King; Mark A Williams; Gerald F Fletcher; Neil F Gordon; Meg Gulanick; Carl N King; Arthur S Leon; Benjamin D Levine; Fernando Costa; Nanette K Wenger
Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs. A statement for healthcare professionals from the American Association for Cardiovascular and Pulmonary Rehabilitation and the American Heart Association.
Journal of cardiopulmonary rehabilitation 2005;25(6):315-20.
2005: Nanette K Wenger; Michael A Weber; Stephen Scheidt
Medicare drug therapy in the elderly: pharmacotherapy, politics, and economics at the crossroads.
The American journal of geriatric cardiology 2005;14(6):282-3.
2005: Michael A Weber; Nanette K Wenger; Stephen Scheidt
A focus on heart failure and other age-related cardiovascular conditions.
The American journal of geriatric cardiology 2005;14(5):221-3.
2005: Viola Vaccarino; Saif S Rathore; Nanette K Wenger; Paul D Frederick; Jerome L Abramson; Hal V Barron; Ajay Manhapra; Susmita Mallik; Harlan Krumholz
Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002.
The New England journal of medicine 2005;353(7):671-82.
2005: Nanette K Wenger
Coronary revascularization in women.
Cardiology in review 2005;13(4):184-9.
2005: Ibrahim R Hanna; Nanette K Wenger
Secondary prevention of coronary heart disease in elderly patients.
American family physician 2005;71(12):2289-96.
2005: Nanette K Wenger
Menopausal hormone therapy: currently no evidence for cardiac protection.
Pediatric blood & cancer 2005;44(7):625-9.
2005: John C LaRosa; Scott M Grundy; David D Waters; Charles L Shear; Philip J Barter; Jean-Charles Fruchart; Antonio M Gotto; Heiner Greten; John J P Kastelein; James Shepherd; Nanette K Wenger
Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
The New England journal of medicine 2005;352(14):1425-35.
2005: Jennifer H Mieres; Leslee J Shaw; Andrew Arai; Matthew J Budoff; Scott D Flamm; W Gregory Hundley; Thomas H Marwick; Lori Mosca; Ayan R Patel; Miguel A Quinones; Rita F Redberg; Kathryn A Taubert; Allen J Taylor; Gregory S Thomas; Nanette K Wenger
Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association.
Circulation 2005;111(5):682-96.
2005: Nanette K Wenger; Tarek Helmy; Amar D Patel; Ibrahim R Hanna
Approaching cardiac arrhythmias in the elderly patient.
MedGenMed : Medscape general medicine 2005;7(4):24.
2005: Tarek Helmy; Amar D Patel; Fadi Alameddine; Nanette K Wenger
Management strategies of dyslipidemia in the elderly: 2005.
MedGenMed : Medscape general medicine 2005;7(4):8.
2005: Kimberly P Champney; Nanette K Wenger
Recognition and prevention of cardiovascular disease in women.
Comprehensive therapy 2005;31(4):255-61.
2005: Nanette K Wenger; Tarek Helmy; Amar D Patel; Stamatios Lerakis
Evidence-based management of coronary artery disease in the elderly--current perspectives.
MedGenMed : Medscape general medicine 2005;7(2):75.
2005: Nanette K Wenger; Tarek Helmy; Bobby V Khan; Amar D Patel
Evidence-based management of acute myocardial infarction in the elderly--current perspectives.
MedGenMed : Medscape general medicine 2005;7(1):73.
2005: Manjula Kurella; Kristine Yaffe; Michael G Shlipak; Nanette K Wenger; Glenn M Chertow
Chronic kidney disease and cognitive impairment in menopausal women.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(1):66-76.
2005: Stephen Scheidt; Nanette K Wenger; Michael Weber
Modern cardiac electrophysiology and the elderly.
The American journal of geriatric cardiology 2005;14(1):6-8.
2004: Nanette K Wenger; Michael A Weber; Stephen Scheidt
Hippocrates, Maimonides, and End-of-Life Issues.
The American journal of geriatric cardiology 2004;13(6):291-2.
2004: Michael A Weber; Nanette K Wenger; Stephen Scheidt
Common cardiac conditions in the elderly are still not well understood.
The American journal of geriatric cardiology 2004;13(5):237-8.
2004: Nanette K Wenger
Diet and exercise for perimenopausal women lifestyle interventions can decrease cardiovascular risk.
Journal of the American College of Cardiology 2004;44(3):586-7.
2004: Nanette K Wenger
Chronic kidney disease is a cardiovascular problem--implications for lipid management.
The American journal of cardiology 2004;94(2):167-8.
2004: Nanette K Wenger; Gabriel Gregoratos; Dalane W Kitzman; Stephen Scheidt; Michael A Weber; Joseph S Alpert
Guidelines of the Cardiogeriatrics Department of the Brazilian Cardiology Society: commentary by Editorial Board Members of The American Journal of Geriatric Cardiology.
The American journal of geriatric cardiology 2004;13(4):209-16.
2004: Michael A Weber; Nanette K Wenger; Stephen Scheidt
The elderly and cardiovascular disease: some differences, but many similarities to their younger counterparts.
The American journal of geriatric cardiology 2004;13(4):178-9.
2004: Nanette K Wenger
Dyslipidemia as a risk factor at elderly age.
The American journal of geriatric cardiology 2004;13(3 Suppl 1):4-9.
2004: Lori Mosca; Lawrence J Appel; Emelia Benjamin; Kathy Berra; Nisha Chandra-Strobos; Rosalind P Fabunmi; Deborah Grady; Constance K Haan; Sharonne N Hayes; Debra R Judelson; Nora L Keenan; Patrick McBride; Suzanne Oparil; Pamela Ouyang; Mehmet C Oz; Michael Mendelsohn; Richard C Pasternak; Vivian W Pinn; Rose Marie Robertson; Karin Schenck-Gustafsson; Cathy A Sila; Sidney C Smith; George Sopko; Anne L Taylor; Brian W Walsh; Nanette K Wenger; Christine L Williams
Evidence-based guidelines for cardiovascular disease prevention in women.
Journal of the American College of Cardiology 2004;43(5):900-21.
2004: Nanette K Wenger; Michael A Weber; Stephen Scheidt
The Cardiovascular Health Study: a national treasure of cardiovascular information about the elderly.
The American journal of geriatric cardiology 2004;13(2):57-8.
2004: Lori Mosca; Lawrence J Appel; Emelia Benjamin; Kathy Berra; Nisha Chandra-Strobos; Rosalind P Fabunmi; Deborah Grady; Constance K Haan; Sharonne N Hayes; Debra R Judelson; Nora L Keenan; Patrick McBride; Suzanne Oparil; Pamela Ouyang; Mehmet C Oz; Michael Mendelsohn; Richard C Pasternak; Vivian W Pinn; Rose Marie Robertson; Karin Schenck-Gustafsson; Cathy A Sila; Sidney C Smith; George Sopko; Anne L Taylor; Brian W Walsh; Nanette K Wenger; Christine L Williams
Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(3):e29-50.
2004: Lori Mosca; Lawrence J Appel; Emelia Benjamin; Kathy Berra; Nisha Chandra-Strobos; Rosalind P Fabumni; Deborah Grady; Constance K Haan; Sharonne N Hayes; Debra R Judelson; Nora L Keenan; Patrick McBride; Suzanne Oparil; Pamela Ouyang; Mehmet C Oz; Michael Mendelsohn; Richard C Pasternak; Vivian W Pinn; Rose Marie Robertson; Karin Schenck-Gustafsson; Cathy A Sila; Sidney C Smith; George Sopko; Anne L Taylor; Brian W Walsh; Nanette K Wenger; Christine L Williams
Summary of the American Heart Association's evidence-based guidelines for cardiovascular disease prevention in women.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(3):394-6.
2004: Liudmila Husak; Viola Vaccarino; Emir Veledar; Nancy V Murrah; Nanette K Wenger
Comparison of angiographic findings among postmenopausal women using unopposed estrogen, estrogen/progestin combinations, and nonusers.
The American journal of cardiology 2004;93(5):563-8.
2004: Nanette K Wenger
You've come a long way, baby: cardiovascular health and disease in women: problems and prospects.
Circulation 2004;109(5):558-60.
2004: Lori Mosca; Lawrence J Appel; Emelia Benjamin; Kathy Berra; Nisha Chandra-Strobos; Rosalind P Fabunmi; Deborah Grady; Constance K Haan; Sharonne N Hayes; Debra R Judelson; Nora L Keenan; Patrick McBride; Suzanne Oparil; Pamela Ouyang; Mehmet C Oz; Michael Mendelsohn; Richard C Pasternak; Vivian W Pinn; Rose Marie Robertson; Karin Schenck-Gustafsson; Cathy A Sila; Sidney C Smith; George Sopko; Anne L Taylor; Brian W Walsh; Nanette K Wenger; Christine L Williams
Evidence-based guidelines for cardiovascular disease prevention in women.
Circulation 2004;109(5):672-93.
2004: David D Waters; John R Guyton; David M Herrington; Mary P McGowan; Nanette K Wenger; Charles L Shear
Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?
The American journal of cardiology 2004;93(2):154-8.
2004: Nanette K Wenger
Menopausal hormone therapy: is there evidence for cardiac protection?.
International urology and nephrology 2004;36(4):617-23.
2004: Michael G Shlipak; Catherine Stehman-Breen; Eric Vittinghoff; Feng Lin; Paul D Varosy; Nanette K Wenger; Curt D Furberg
Creatinine levels and cardiovascular events in women with heart disease: do small changes matter?
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(1):37-44.
2003: Nanette K Wenger
Coronary heart disease: the female heart is vulnerable.
Progress in cardiovascular diseases 2003;46(3):199-229.
2003: Nanette K Wenger
HT and CVD prevention. from myth to reality.
Fertility and sterility 2003;80 Suppl 4():10-4; quiz 54-5.
2003: Nanette K Wenger
Is what's good for the gander good for the goose?
The Journal of thoracic and cardiovascular surgery 2003;126(4):929-31.
2003: Michael A Weber; Nanette K Wenger; Stephen Scheidt
New frontiers in cardiovascular aging.
The American journal of geriatric cardiology 2003;12(5):281-2.
2003: Stephen Scheidt; Nanette K Wenger; Michael A Weber
Drug therapy in the elderly.
The American journal of geriatric cardiology 2003;12(4):223-4.
2003: Paul D Thompson; David Buchner; Ileana L Pina; Gary J Balady; Mark A Williams; Bess H Marcus; Kathy Berra; Steven N Blair; Fernando Costa; Barry Franklin; Gerald F Fletcher; Neil F Gordon; Russell Pate; Beatriz L Rodriguez; Antronette K Yancey; Nanette K Wenger
Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity).
Circulation 2003;107(24):3109-16.
2003: Nanette K Wenger
Nanette Kass Wenger, MD: a conversation with the editor [interviewed by William Clifford Roberts].
The American journal of cardiology 2003;91(10):1203-24.
2003: Nanette K Wenger; Stephen Scheidt; Michael A Weber
Anticoagulation at elderly age: the challenge to do better.
The American journal of geriatric cardiology 2003;12(3):151-2.
2003: Rodolfo Paoletti; Nanette K Wenger
Review of the International Position Paper on Women's Health and Menopause: a comprehensive approach.
Circulation 2003;107(9):1336-9.
2003: Nanette K Wenger
Menopausal hormone therapy and cardiovascular protection: state of the data 2003.
Journal of the American Medical Women's Association (1972) 2003;58(4):236-9.
2003: W Dallas Hall; Luther Clark; Nanette K Wenger; Jackson T Wright; Shiriki K Kumanyika; Karol Watson; Ella W Horton; John M Flack; Keith C Ferdinand; James R Gavin; James _ Reed; Elijah Saunders; Welton O'Neal
For the patient. What is the Metabolic Syndrome and why is it important?
Ethnicity & disease 2003;13(4):546.
2003: W Dallas Hall; Luther Clark; Nanette K Wenger; Jackson T Wright; Shiriki K Kumanyika; Karol Watson; Ella W Horton; John M Flack; Keith C Ferdinand; James R Gavin; James _ Reed; Elijah Saunders; Welton O'Neal
The Metabolic Syndrome in African Americans: a review.
Ethnicity & disease 2003;13(4):414-28.
2003: Nanette K Wenger
Reflections of a "lady doctor".
Journal of the Medical Association of Georgia 2003;92(2):13-4.
2003: Nanette K Wenger
[The current state of hormonal prevention of coronary heart disease in menopausal women].
Revista española de cardiología 2003;56(1):1-8.
2003: Nanette K Wenger; Michael A Weber; Stephen Scheidt
Data-driven clinical care.
The American journal of geriatric cardiology 2003;12(1):5-6.
2002: Nanette K Wenger; Elizabeth Barrett-Connor; Peter Collins; Deborah Grady; Marcel Kornitzer; Lori Mosca; Andreas Sashegyi; Simin K Baygani; Pamela W Anderson; Elena Moscarelli
Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial.
The American journal of cardiology 2002;90(11):1204-10.
2002: Stephen Scheidt; Nanette K Wenger; Michael A Weber
Atrial fibrillation: many therapeutic options, but great uncertainty about optimal treatment.
The American journal of geriatric cardiology 2002;11(6):350-1.
2002: Nanette K Wenger
Usefulness of lipid-lowering therapy in elderly patients.
The American journal of cardiology 2002;90(8):870-1.
2002: Michael A Weber; Nanette K Wenger; Stephen Scheidt
Management of heart failure in the elderly: still much to be learned.
The American journal of geriatric cardiology 2002;11(5):281-2.
2002: Nanette K Wenger
Coronary heart disease and women: magnitude of the problem.
Cardiology in review 2002;10(4):211-3.
2002: Nanette K Wenger; Stephen Scheidt; Michael Weber
Drug treatment of cardiovascular problems at elderly age.
The American journal of geriatric cardiology 2002;11(4):214, 232.
2002: Nanette K Wenger
Cardiovascular effects of raloxifene: the potential for cardiovascular protection in women.
Diabetes, obesity & metabolism 2002;4(3):166-76.
2002: W Craig Hooper; Nicole Dowling; Nanette K Wenger; Anne Dilley; Dorothy Ellingsen; Bruce Evatt
Relationship of venous thromboembolism and myocardial infarction with the renin-angiotensin system in African-Americans.
American journal of hematology 2002;70(1):1-8.
2002: A Altobelli; Stephen Scheidt; Nanette K Wenger; Michael Weber
Surgical coronary revascularization in the elderly.
The American journal of geriatric cardiology 2002;11(3):157-9.
2002: Mark A Williams; Jerome L Fleg; Philip A Ades; Bernard R Chaitman; Nancy Houston Miller; Syed M Mohiuddin; Ira S Ockene; C Barr Taylor; Nanette K Wenger
Secondary prevention of coronary heart disease in the elderly (with emphasis on patients > or =75 years of age): an American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention.
Circulation 2002;105(14):1735-43.
2002: Nanette K Wenger
Women, heart failure, and heart failure therapies.
Circulation 2002;105(13):1526-8.
2002: Michael Weber; Nanette K Wenger; Stephen Scheidt
The changing pattern of coronary heart disease in the elderly.
The American journal of geriatric cardiology 2002;11(2):79-80.
2002: Curt D Furberg; Eric Vittinghoff; Michael Davidson; David M Herrington; Joel A Simon; Nanette K Wenger; Stephen B Hulley
Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learned.
Circulation 2002;105(8):917-22.
2002: Nanette K Wenger
Clinical characteristics of coronary heart disease in women: emphasis on gender differences.
Cardiovascular research 2002;53(3):558-67.
2002: Sally E McNagny; Nanette K Wenger
Postmenopausal hormone-replacement therapy.
The New England journal of medicine 2002;346(1):63-5.
2002: Nanette K Wenger; Stephen Scheidt; Michael A Weber
Hypertension at elderly age: what we know and what we must learn.
The American journal of geriatric cardiology 2002;11(1):8-8.
2001: Michael G Shlipak; J A Simon; Deborah Grady; F Lin; Nanette K Wenger; Curt D Furberg
Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease.
Journal of the American College of Cardiology 2001;38(3):705-11.
2001: Lori Mosca; Elizabeth Barrett-Connor; Nanette K Wenger; Peter Collins; Deborah Grady; Marcel Kornitzer; Elena Moscarelli; S Paul; Theressa J Wright; Jeffrey D Helterbrand; Pamela W Anderson
Design and methods of the Raloxifene Use for The Heart (RUTH) study.
The American journal of cardiology 2001;88(4):392-5.
2001: Anne Dilley; W Craig Hooper; M El-Jamil; Mary Renshaw; Nanette K Wenger; Bruce Evatt
Mutations in the genes regulating methylene tetrahydrofolate reductase (MTHFR C-->T677) and cystathione beta-synthase (CBS G-->A919, CBS T-->c833) are not associated with myocardial infarction in African Americans.
Thrombosis research 2001;103(2):109-15.
2001: P Z Castellano; Nanette K Wenger; William Graves
Adherence to screening guidelines for breast and cervical cancer in postmenopausal women with coronary heart disease: an ancillary study of volunteers for hers.
Journal of women's health & gender-based medicine 2001;10(5):451-61.
2001: Nanette K Wenger
A cardiologist's view of hormone replacement therapy and alternatives for cardioprotection.
Journal of women's health & gender-based medicine 2001;10(3):257-60.
2000: Harland Austin; W Craig Hooper; Cathy Lally; Anne Dilley; Dorothy Ellingsen; C Wideman; Nanette K Wenger; P Rawlins; V Silva; Bruce Evatt
Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans.
Journal of clinical epidemiology 2000;53(10):997-1001.
2000: W Craig Hooper; Cathy Lally; Harland Austin; Mary Renshaw; Anne Dilley; Nanette K Wenger; DJ Phillips; Carolyn Whitsett; P Rawlins; Bruce Evatt
The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism.
Thrombosis research 2000;99(3):223-30.
2000: Deborah Grady; Nanette K Wenger; David Herrington; S Khan; Curt D Furberg; Donald B Hunninghake; Eric Vittinghoff; Stephen B Hulley
Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.
Annals of internal medicine 2000;132(9):689-96.
2000: Nanette K Wenger
Lipid management and control of other coronary risk factors in the postmenopausal woman.
Journal of women's health & gender-based medicine 2000;9(3):235-43.
2000: Sidney C Smith; Ezra A Amsterdam; Gary J Balady; Robert O Bonow; Gerald F Fletcher; Victor F Froelicher; G Heath; Marian C Limacher; J Maddahi; D Pryor; R F Redberg; E Roccella; T Ryan; Lynn A Smaha; Nanette K Wenger
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: tests for silent and inducible ischemia: Writing Group II.
Circulation 2000;101(1):E12-6.
1999: W Craig Hooper; Cathy Lally; Harland Austin; Jane Benson; Anne Dilley; Nanette K Wenger; Carolyn Whitsett; P Rawlins; Bruce Evatt
The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans.
Chest 1999;116(4):880-6.
1999: Nanette K Wenger; Deborah Grady
Postmenopausal hormone therapy, SERMs, and coronary heart disease in women.
Journal of endocrinological investigation 1999;22(8):616-24.
1999: Nanette K Wenger
Should women have a different risk assessment from men for primary prevention of coronary heart disease?
Journal of women's health & gender-based medicine 1999;8(4):465-7.
1999: Nanette K Wenger
Women, myocardial infarction, and coronary revascularization: concordant and discordant clinical trial and registry data.
Cardiology in review 1999;7(2):117-20.
1998: Anne Dilley; Harland Austin; W Craig Hooper; M El-Jamil; Carolyn Whitsett; Nanette K Wenger; Jane Benson; Bruce Evatt
Prevalence of the prothrombin 20210 G-to-A variant in blacks: infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects.
The Journal of laboratory and clinical medicine 1998;132(6):452-5.
1998: Elizabeth Barrett-Connor; Nanette K Wenger; Deborah Grady; Lori Mosca; Peter Collins; Marcel Kornitzer; David A Cox; Elena Moscarelli; Pamela W Anderson
Coronary heart disease in women, randomized clinical trials, HERS and RUTH.
Maturitas 1998;31(1):1-7.
1998: Nanette K Wenger
Lipid metabolism, physical activity, and postmenopausal hormone therapy.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;32(5 Suppl 3):S80-8.
1998: Elizabeth Barrett-Connor; Nanette K Wenger; Deborah Grady; Lori Mosca; Peter Collins; Marcel Kornitzer; David A Cox; Elena Moscarelli; Pamela W Anderson
Hormone and nonhormone therapy for the maintenance of postmenopausal health: the need for randomized controlled trials of estrogen and raloxifene.
Journal of women's health / the official publication of the Society for the Advancement of Women's Health Research 1998;7(7):839-47.
1998: David M Herrington; J Fong; C T Sempos; D M Black; Helmut Schrott; Pentti M Rautaharju; P S Bachorik; Roger S Blumenthal; S Khan; Nanette K Wenger
Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III)
American heart journal 1998;136(1):115-24.
1998: W Craig Hooper; Anne Dilley; Harland Austin; Nanette K Wenger; Jane Benson; Bruce Evatt; V Silva; P Rawlins
Absence of mutations at APC cleavage sites Arg306 in factor V and Arg336, Arg562 in factor VIII in African-Americans.
Thrombosis and haemostasis 1998;79(1):236.
1998: Anne Dilley; Harland Austin; W Craig Hooper; Cathy Lally; M J Ribeiro; Nanette K Wenger; V Silva; P Rawlins; Bruce Evatt
Relation of three genetic traits to venous thrombosis in an African-American population.
American journal of epidemiology 1998;147(1):30-5.
1997: SE McNagny; Nanette K Wenger; A Hulton
Personal use of postmenopausal hormone replacement therapy by women physicians in the United States.
Annals of internal medicine 1997;127(12):1093-6.
1997: Nanette K Wenger
Rehabilitation of the coronary artery disease patient: capturing patients.
The American journal of cardiology 1997;80(8B):66H-68H.
1997: Nanette K Wenger
Coronary heart disease: a substantial threat to women.
Journal of the Medical Association of Georgia 1997;86(3):187-91.
1996: W Craig Hooper; Anne Dilley; M J Ribeiro; Jane Benson; Harland Austin; V Silva; P Rawlins; Nanette K Wenger; Bruce Evatt
A racial difference in the prevalence of the Arg506-->Gln mutation.
Thrombosis research 1996;81(5):577-81.